Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 1.950
-0.070 (-3.47%)
Oct 7, 2026, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 727.51 million as of October 7, 2026. Its market cap has decreased by -61.87% in one year.
Market Cap
727.51M
Enterprise Value
549.25M
Revenue
10.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.95
ChartMarket Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 727.51M, an increase of 89.36%. That is a compound annual growth rate of 13.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 727.51M | -42.14% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.65B |
| Neuren Pharmaceuticals | 2.57B |
| PYC Therapeutics | 2.42B |
| Clinuvel Pharmaceuticals | 408.47M |
| Starpharma Holdings | 381.48M |
| Racura Oncology | 376.45M |
| Tetratherix | 342.23M |
| BLS Pharmaceuticals | 234.91M |